Patent details

EP3349740 Title: CO-THERAPY COMPRISING CANAGLIFLOZIN AND PHENTERMINE FOR USE IN THE TREATMENT OF OBESITY AND OBESITY RELATED DISORDERS

Basic Information

Publication number:
EP3349740
PCT Application Number:
US2016051435
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP167710433
PCT Publication Number:
WO2017048670
First applicant's nationality:
Translation Language:
EPO Publication Language:
English Title of Invention:
CO-THERAPY COMPRISING CANAGLIFLOZIN AND PHENTERMINE FOR USE IN THE TREATMENT OF OBESITY AND OBESITY RELATED DISORDERS
French Title of Invention:
CO-THÉRAPIE COMPRENANT DE LA CANAGLIFLOZINE ET DE LA PHENTERMINE POUR SON UTILISATION DANS LE TRAITEMENT DE L'OBÉSITÉ ET DES TROUBLES LIÉS À L'OBÉSITÉ
German Title of Invention:
CO-THERAPIE MIT CANAGLIFLOZIN UND PHENTERMIN ZUR VERWENDUNG IN DER BEHANDLUNG VON FETTLEIBIGKEIT UND MIT FETTLEIBIGKEIT ZUSAMMENHÄNGENDEN ERKRANKUNGEN
SPC Number:

Dates

Filing date:
13/09/2016
Grant date:
21/04/2021
EP Publication Date:
25/07/2018
PCT Publication Date:
23/03/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/04/2021
EP B1 Publication Date:
21/04/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/09/2021
Expiration date:
13/09/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/04/2021
 
 

Name:
Janssen Pharmaceutica NV
Address:
Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

Inventor

1

Name:
STEIN, Peter P.
Address:
United States (US)

2

Name:
ROSENTHAL, Norman R.
Address:
United States (US)

3

Name:
POLIDORI, David C.
Address:
United States (US)

4

Name:
ROTHENBERG, Paul
Address:
United States (US)

5

Name:
WAYS, Douglas K.
Address:
United States (US)

Priority

1

Priority Number:
201562218842 P
Priority Date:
15/09/2015
Priority Country:
United States (US)

2

Priority Number:
201662306110 P
Priority Date:
10/03/2016
Priority Country:
United States (US)

3

Priority Number:
201615262038
Priority Date:
12/09/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/137; A61K 31/7042; A61P 3/04; A61P 3/00; A61P 9/00; A61P 9/12; A61P 13/00; A61P 1/16; A61P 43/00;

Publication

European Patent Bulletin

Issue number:
202116
Publication date:
21/04/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages